Treatment options for muscle-invasive urothelial cancer for patients who were not eligible for cystectomy or neoadjuvant chemotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin: Report of Southwest Oncology Group Trial 8733

Celestia S. Higano, Catherine M. Tangen, Wael A. Sakr, James Faulkner, Saul E. Rivkin, Frederick J. Meyers, Maha Hussain, Laurence H. Baker, Kenneth J. Russell, E. David Crawford, Connie Barnes*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Treatment options for muscle-invasive urothelial cancer for patients who were not eligible for cystectomy or neoadjuvant chemotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin: Report of Southwest Oncology Group Trial 8733'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

INIS